project id: TCGA-BRCA; case submitter id: TCGA-A2-A3XS; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 7.9; age at index: 62; days to birth: -23000; days to death: 1032; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1941; year of death: 2005; age at diagnosis: 23000; ajcc pathologic m: M0; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2003; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 3355; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-A2-A3XS-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 13.0; percent tumor cells: 85.0; percent tumor nuclei: 68.0;